171 related articles for article (PubMed ID: 27409347)
1. The down-regulated ING5 expression in lung cancer: a potential target of gene therapy.
Zhao S; Yang XF; Shen DF; Gao Y; Shi S; Wu JC; Liu HX; Sun HZ; Su RJ; Zheng HC
Oncotarget; 2016 Aug; 7(34):54596-54615. PubMed ID: 27409347
[TBL] [Abstract][Full Text] [Related]
2. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
3. ING5-mediated antineuroblastoma effects of suberoylanilide hydroxamic acid.
Wu JC; Jiang HM; Yang XH; Zheng HC
Cancer Med; 2018 Sep; 7(9):4554-4569. PubMed ID: 30091530
[TBL] [Abstract][Full Text] [Related]
4. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
[TBL] [Abstract][Full Text] [Related]
5. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
[TBL] [Abstract][Full Text] [Related]
6. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
7. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
[TBL] [Abstract][Full Text] [Related]
8. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
Zhang GJ; Zhao J; Jiang ML; Zhang LC
Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
[TBL] [Abstract][Full Text] [Related]
9. ING5 suppresses breast cancer progression and is regulated by miR-24.
Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells.
Lu H; Yang XF; Tian XQ; Tang SL; Li LQ; Zhao S; Zheng HC
Oncotarget; 2016 Aug; 7(35):56508-56525. PubMed ID: 27447743
[TBL] [Abstract][Full Text] [Related]
11. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
12. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
13. The roles of ING5 in gliomas: a good marker for tumorigenesis and a potential target for gene therapy.
Zhao S; Zhao ZJ; He HY; Wu JC; Ding XQ; Yang L; Jia N; Li ZJ; Zheng HC
Oncotarget; 2017 Aug; 8(34):56558-56568. PubMed ID: 28915612
[TBL] [Abstract][Full Text] [Related]
14. BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
Zhao S; Chen SR; Yang XF; Shen DF; Takano Y; Su RJ; Zheng HC
Oncotarget; 2017 Jan; 8(5):7502-7520. PubMed ID: 27447746
[TBL] [Abstract][Full Text] [Related]
15. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway.
Gao W; Han J
Biomed Pharmacother; 2018 Feb; 98():265-270. PubMed ID: 29272787
[TBL] [Abstract][Full Text] [Related]
17. ING5 Inhibits Migration and Invasion of Esophageal Cancer Cells by Downregulating the IL-6/CXCL12 Signaling Pathway.
Wang Y; Tan J; Li J; Chen H; Wang W
Technol Cancer Res Treat; 2021; 20():15330338211039940. PubMed ID: 34520285
[TBL] [Abstract][Full Text] [Related]
18. The nucleocytoplasmic translocation and up-regulation of ING5 protein in breast cancer: a potential target for gene therapy.
Ding XQ; Zhao S; Yang L; Zhao X; Zhao GF; Zhao SP; Li ZJ; Zheng HC
Oncotarget; 2017 Oct; 8(47):81953-81966. PubMed ID: 29137236
[TBL] [Abstract][Full Text] [Related]
19. The roles of ING5 expression in ovarian carcinogenesis and subsequent progression: a target of gene therapy.
Zheng HC; Zhao S; Song Y; Ding XQ
Oncotarget; 2017 Nov; 8(61):103449-103464. PubMed ID: 29262575
[TBL] [Abstract][Full Text] [Related]
20. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
